Skip to content

Evaluation of Some Biochemical Markers of Bone Turnover in Childern and Adolescents With Type 1 Diabetes

Evaluation of Some Biochemical Markers of Bone Turnover in Childern and Adolescents With Type 1 Diabetes

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05892848
Enrollment
100
Registered
2023-06-07
Start date
2023-06-10
Completion date
2024-06-30
Last updated
2023-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes

Brief summary

Type 1 diabetes is associated with many longterm complications as retinopathy,neuropathy and nephropathy. Recently, several studies have linked type 1 diabetes to bone fragility.Studies conducted on patients with type 1 diabetes have concluded that bone is negatively affected in type 1 diabetes with impaired bone density,increased fracture risk and impaired bone turnover markers.

Interventions

DIAGNOSTIC_TESTserum ostecalcin,serum sclerostin and parathroid profile

evaluation of bone turnover markers in blood

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
3 Years to 16 Years
Healthy volunteers
Yes

Inclusion criteria

* childern and adolsecents below 16 years of age diagnsed with type 1 diabetes for at least 1 year age and sex-matched control childern and adolsecents will be included

Exclusion criteria

* childern and adolescents with congenital bone disease, those with disorders of the parathyroid gland and those with chronic kidney disease.

Design outcomes

Primary

MeasureTime frameDescription
level of serum ostecalcin, sclerostin in patients with type 1 diabetes ann d their age and sex matched control12 monthsmarkers of bone turnover in patients with type 1 diabetes and their matched control

Countries

Egypt

Contacts

Primary ContactHajar M Ismail, resident
hagermoamen@med.sohag.edu.eg01068447853
Backup ContactAhmed M Monir, assistant professor

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026